Results 51 to 60 of about 2,213 (186)

Simultaneous detection of Marburg virus and Ebola virus with TaqMan‐based multiplex real‐time PCR method

open access: yesJournal of Clinical Laboratory Analysis, Volume 35, Issue 6, June 2021., 2021
Marburg virus (MARV) and Ebola virus (EBOV) are acute infections with high case fatality rates. It is great significance for epidemic monitoring and prevention and control of infectious diseases by development of a rapid, specific and sensitive quantitative PCR method to detect two pathogens simultaneously.
Zhikang Yu   +3 more
wiley   +1 more source

Analysis of the multifunctionality of Marburg virus VP40

open access: yesJournal of General Virology, 2018
The Marburg virus (MARV) matrix protein, VP40, is a multifunctional protein that is essential for the assembly and release of viral particles, inhibition of the interferon response and viral transcription/replication. VP40 is assumed to be present as soluble monomers and membrane-bound higher-order oligomers.
Stephan Becker   +3 more
openaire   +3 more sources

Obtaining Recombinant Antigens for the Development of Serological Diagnosis of Marburg Fever

open access: yesПроблемы особо опасных инфекций, 2021
Aim. Production of recombinant viral antigens of the main immunodominant proteins: glycoprotein (GPΔMLD), nucleoprotein (NP) and matrix protein (VP40) of the Marburg virus, as well as the study of their antigenic and immunogenic properties.Materials and ...
N. V. Volkova   +6 more
doaj   +1 more source

Plasma membrane association facilitates conformational changes in the Marburg virus protein VP40 dimer [PDF]

open access: yes, 2017
Filovirus infections cause hemorrhagic fever in humans and non-human primates that often results in high fatality rates. The Marburg virus is a lipid-enveloped virus from the Filoviridae family and is closely related to the Ebola virus.
Bhattarai, Nisha   +4 more
core   +1 more source

Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Monoclonal antibodies (mAbs) are presently the most promising treatment against Ebola virus disease (EVD), and cocktail of two or more antibodies likely confers protection through complementary mechanisms.
Dong-Shan Yu   +10 more
doaj   +1 more source

Data from: A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection [PDF]

open access: yes, 2017
The dataset contains findings and information from 51 seroprevelance studies performed from on samples collected from 1961 to 2016. These investigated 84 exposure-defined subgroups of subjects reported to have had no symptoms of EVD during the outbreak ...
Bower, Hilary, Glynn, Judith
core   +2 more sources

Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles [PDF]

open access: yesThe Journal of Infectious Diseases, 2018
Ebola virus (EBOV) mainly targets myeloid cells; however, extensive death of T cells is often observed in lethal infections. We have previously shown that EBOV VP40 in exosomes causes recipient immune cell death.Using VP40-producing clones, we analyzed donor cell cycle, extracellular vesicle (EV) biogenesis, and recipient immune cell death ...
Fatah Kashanchi   +14 more
openaire   +3 more sources

Charakterisierung der Rolle des endosomalen Recycling-Systems für den intrazellulären Transport des Marburg Virus Glykoproteins [PDF]

open access: yes, 2019
Das Marburg Virus (MARV), das zur Familie der Filoviridae gezählt wird, ist ein Erreger schwerer Fieber mit Letalitätsraten von bis zu 90 %. Das Glykoprotein GP stellt das einzige Oberflächenprotein des MARV dar und daher ist sein korrekter Transport zu ...
Halwe, Sandro
core   +1 more source

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors

open access: yesInternational Journal of Molecular Sciences, 2023
The Ebola virus (EBOV) is still highly infectious and causes severe hemorrhagic fevers in primates. However, there are no regulatorily approved drugs against the Ebola virus disease (EVD). The highly virulent and lethal nature of EVD highlights the need to develop therapeutic agents.
Emmanuel Broni   +8 more
openaire   +2 more sources

Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus [PDF]

open access: yes, 2016
Multilingual abstracts in the six official working languages of the United Nations.
Aiping Lu   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy